RA CAPITAL MANAGEMENT, L.P. received a stock award from ACUMEN PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2026ACC: 0001231919-26-000604
Director10% Owner
Since Jun 2021
+88.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
88.75K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+35.50K
Price / share
—
Trade value
—
% of position
277.3%
6/3/2026
12.80K→48.30K
Total
Net shares
+35.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/3/2026 | A · Award | +35.50K | — | — | 277.3% | 12.80K | 48.30K |
| Total | +35.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Indirect
Converts to
Common Stock
53.25K shares
Shares
+53.25K
Strike price
2.29
Held after
53.25K
Exercisable
—
6/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Indirect | Common Stock53.25K shares | 6/3/2026 | A · Award | +53.25K | 2.29 | — | 53.25K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned19.10M
Common Stock
IndirectShares owned1.30M
Common Stock
IndirectShares owned588.85K
Total
20.99M indirect20.99M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 19.10M | Indirect |
| Common Stock | 1.30M | Indirect |
| Common Stock | 588.85K | Indirect |
| Total | 20.99M | 20.99M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported